Search results
Trump Media stock jumps 9% after the CEO asks Congress to investigate short-selling firms
Quartz· 1 hour agoLate last month, Nunes called on Congress to carry out a “thorough...company claimed was “unlawful...
Trump Media pushes House to probe 8 firms over short-selling of DJT shares
CNBC· 4 hours ago"I believe quick action is necessary to protect retail shareholders, identify wrongdoers, and...
... Letter to the Relevant Committees of the US Congress To Urge Investigation Into the "Potential...
Wccftech· 5 hours ago...rightly or wrongly, Trump Media and Technology Group (NASDAQ: DJT) is convinced that its stock is...
Trump Media Stock (DJT) At Risk Of A New Short Selling Plunge
Forbes· 2 days agoThe Trump Media anti-short selling campaign has unwittingly played into short sellers' hands. After ...
Time to Pounce: 2 Ultra-High-Yield Monthly Dividend Stocks Begging to Be Bought in May
Motley Fool via Yahoo Finance· 11 hours agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...
Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered
Motley Fool via Yahoo Finance· 1 day agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...
Peering Into Sun Communities's Recent Short Interest - Sun Communities (NYSE:SUI)
Benzinga· 4 hours agoSun Communities's SUI short percent of float has fallen 5.39% since its last report. Based on its trading volume, it would take traders 2.35 days to cover their short ...
Cigna (CI) Q1 Earnings Beat on Client Wins in Evernorth Unit
Zacks via Yahoo Finance· 3 hours agoCigna's (CI) Q1 results reflect strong organic growth in the Evernorth Health Services unit. It...
Where Will Lucid Motors Stock Be in 5 Years?
Motley Fool via Yahoo Finance· 9 hours agoThis strategy can raise capital but hurts current investors' claims on the company's future...industry observers -- earning a spot in Car and Driver's 10...
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 15 hours agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...
